Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Peptimmune, Novartis Sign $500M Deal for MS Drug
Peptimmune, Novartis Sign $500M Deal for MS Drug
Peptimmune, Novartis Sign $500M Deal for MS Drug
Submitted by
admin
on January 17, 2009 - 9:12am
Source:
Bioworld
News Tags:
PeptImmune
Novartis
MS
multiple sclerosis
Headline:
Peptimmune, Novartis Sign $500M Deal for MS Drug
Do Not Allow Advertisers to Use My Personal information
